These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 12227069)

  • 1. [Effect of new chemotherapeutic methods on the biologic tissue environment and on the immune status of patients with breast cancer].
    Sidorenko IuS; Zlatnik EIu; Vladimirova LIu; Zakora GI
    Vopr Onkol; 2002; 48(2):202-5. PubMed ID: 12227069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Optimal conditions for producing immunomodulating effect of epithalamine as component of neoadjuvant chemotherapy using autoplasma and autoblood in patients with locally advanced breast cancer].
    Zlamnik EIu; Vladimirova LIu; Zakora GI
    Vopr Onkol; 2004; 50(3):357-60. PubMed ID: 15318714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of CD4+CD25+ T cells in breast cancer patients and its significance].
    Liu JT; Yue J; Ren XB; Li H
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):423-5. PubMed ID: 16188129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency.
    Gervais A; Levêque J; Bouet-Toussaint F; Burtin F; Lesimple T; Sulpice L; Patard JJ; Genetet N; Catros-Quemener V
    Breast Cancer Res; 2005; 7(3):R326-35. PubMed ID: 15987427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A novel method of drug-free immunocorrection by exposing cancer patients' blood to alternating magnetic field].
    Zlatnik EIu; Zakora GI; Starzhetskaia MV
    Vopr Onkol; 2004; 50(1):50-4. PubMed ID: 15088521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The concentration of tissue--type plasminogen activator (t-PA) in extracts of breast cancer tissue].
    Ziółkowska E; Pietrusińska E; Łozyńska-Podhrebelna D
    Pol Merkur Lekarski; 2008 Dec; 25(150):489-94. PubMed ID: 19205379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response.
    Lau GI; Loo WT; Chow LW
    Biomed Pharmacother; 2007 Oct; 61(9):562-5. PubMed ID: 17913448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
    Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
    Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of systemic chemotherapy on clinical status and biological and immunologic markers in patients with breast cancer].
    Orlova RV; Chernetsova LF; Matveeva ON
    Vopr Onkol; 2007; 53(4):414-8. PubMed ID: 17969403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.
    Guarneri V; Broglio K; Kau SW; Cristofanilli M; Buzdar AU; Valero V; Buchholz T; Meric F; Middleton L; Hortobagyi GN; Gonzalez-Angulo AM
    J Clin Oncol; 2006 Mar; 24(7):1037-44. PubMed ID: 16505422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy.
    Johnston S; Trudeau M; Kaufman B; Boussen H; Blackwell K; LoRusso P; Lombardi DP; Ben Ahmed S; Citrin DL; DeSilvio ML; Harris J; Westlund RE; Salazar V; Zaks TZ; Spector NL
    J Clin Oncol; 2008 Mar; 26(7):1066-72. PubMed ID: 18212337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer.
    Arpino G; Ciocca DR; Weiss H; Allred DC; Daguerre P; Vargas-Roig L; Leuzzi M; Gago F; Elledge R; Mohsin SK
    Breast Cancer Res Treat; 2005 Jul; 92(1):69-75. PubMed ID: 15980993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels.
    Geisler J; Helle H; Ekse D; Duong NK; Evans DB; Nordbø Y; Aas T; Lønning PE
    Clin Cancer Res; 2008 Oct; 14(19):6330-5. PubMed ID: 18829517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of HER2 ECD can determine the response rate to low dose oral cyclophosphamide and methotrexate in patients with advanced stage breast carcinoma.
    Sandri MT; Johansson H; Colleoni M; Zorzino L; Passerini R; Orlando L; Viale G
    Anticancer Res; 2004; 24(2C):1261-6. PubMed ID: 15154657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
    Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
    Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of eIF4E reduction after neoadjuvant therapy in breast cancer.
    Hiller DJ; Chu Q; Meschonat C; Panu L; Burton G; Li BD
    J Surg Res; 2009 Oct; 156(2):265-9. PubMed ID: 19665145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer.
    Stearns V; Singh B; Tsangaris T; Crawford JG; Novielli A; Ellis MJ; Isaacs C; Pennanen M; Tibery C; Farhad A; Slack R; Hayes DF
    Clin Cancer Res; 2003 Jan; 9(1):124-33. PubMed ID: 12538460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.
    Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L
    Breast Cancer Res Treat; 2006 Aug; 98(3):241-8. PubMed ID: 16670941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.